Hexagon Nutrition IPO Details
Hexagon Nutrition IPO Summary
Hexagon Nutrition IPO opens for subscription on 05 Jun 2026 and closes on 09 Jun 2026.The IPO will be listed on NSE, BSE with the tentative listing date set for 12 Jun 2026.
Hexagon Nutrition IPO price band has been fixed at ₹42 – ₹45 per share. The face value is ₹1 per share with a lot size of 333.
Hexagon Nutrition IPO total issue size comprises 3,08,59,704 shares (aggregating up to ₹138.87 Cr). This includes a fresh issue of 3,08,59,704 shares (aggregating up to ₹0.00 Cr.). Offer for Sale consists of 3,08,59,704 shares (aggregating up to ₹138.87 Cr). Pre-issue shareholding stands at 12,29,18,109, which will increase to 12,29,18,109 post-issue.
Hexagon Nutrition IPO carries a ₹2.75 (6.11%) GMP, reflecting investor sentiment.
Hexagon Nutrition IPO Lot Size :Retail Minimum is 1 lot (333 shares) amounting to ₹14,985. Retail Maximum is 13 lots (4,329 shares) amounting to ₹194,805. SHNI Minimum is 14 lots (4,662 shares) amounting to ₹209,790. SHNI Maximum is 66 lots (21,978 shares) amounting to ₹989,010. BHNI Minimum is 67 lots (22,311 shares) amounting to ₹1,003,995.
Hexagon Nutrition IPO Details
Hexagon Nutrition IPO Subscription
Hexagon Nutrition IPO Application Wise Breakup (Approx)
Hexagon Nutrition IPO Dates
- 05 Jun 2026Opening dateOpen
- 09 Jun 2026Closing dateClose
- 10 Jun 2026Allotment Date Allotment
- 11 Jun 2026Initiation of RefundsRefund
- 11 Jun 2026Credit of SharesCredit
- 12 Jun 2026Listing dateListing
Hexagon Nutrition IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 333 | ₹14,985 |
| Retail Maximum | 13 | 4329 | ₹194,805 |
| SHNI Minimum | 14 | 4662 | ₹209,790 |
| SHNI Maximum | 66 | 21978 | ₹989,010 |
| BHNI Minimum | 67 | 22311 | ₹1,003,995 |
Hexagon Nutrition IPO Reservation
Promoter Holding
Documents
Hexagon Nutrition IPO Valuations
Hexagon Nutrition Financial Information
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
| Amount in ₹ Crore | ||||
About Hexagon Nutrition IPO
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods.
The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports.
Its product portfolio is classified into three segments:
- Branded wellness and clinical nutrition products (B2C)
- Premix formulations (B2B2C)
- Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives
Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence.
The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025.
Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Strength Of Hexagon Nutrition IPO
- A fully integrated holistic nutrition company offering end-to-end solutions across the value chain and a market leader in customized micronutrient formulations.
- Recognized wellness and clinical nutrition brand in the market.
- Long Standing Relationships with our customers.
- Established R&D capabilities with focus on innovation.
- Manufacturing capabilities of products with quality and food safety procedures.
- Well established pan India omnichannel distribution with presence across various geographies.
- Professional turned entrepreneur promoters with experienced management team.
- Track record of growth in financial performance.
Risk Of Hexagon Nutrition IPO
- We are significantly dependent on the premix formulation segment for a substantial portion of our revenues. During the nine month period ended December 31, 2025, Fiscal 2025, Fiscal 2024, and Fiscal 2023, revenue from the premix formulations segment amounted to Rs. 1,377.26 million, Rs. 1,546.95 million, Rs. 1,333.13 million, and Rs. 1,527.99 million, respectively, contributing 51.47%, 47.61%, 44.78%, and 54.86% of our revenue from operations for the respective Fiscals. Any adverse development affecting this segment may have a material adverse effect on our business, financial condition, and results of operations.
- We are dependent on a limited number of customers for a significant portion of our revenue. During the nine month period ended December 31, 2025, Fiscal 2025, Fiscal 2024, and Fiscal 2023, revenue from our top 10 customers aggregated to Rs. 1,118.97 million, Rs. 1,490.49 million, Rs. 1,453.69 million, and Rs. 1,271.29 million, constituting approximately 41.82%, 45.87%, 48.83%, and 45.65% of our revenue from operations, respectively. Loss of one or more such customers or a reduction in their order volumes may adversely affect our business, financial condition, and results of operations.
- Reconstruction of a portion of our Nashik Facility pursuant to past regulatory actions may lead to temporary production disruptions, operational inefficiencies, and potential revenue impact
- Sale of expired, defective, or non-compliant products, or failure to meet applicable quality standards, could expose us to significant liability, damage our reputation, and adversely affect our business, results of operations, and financial condition.
- We do not have long-term contracts with our raw material suppliers, and volatility in raw material prices or adverse sourcing conditions may adversely impact our operations, profitability, and financial performance.
- Our efforts to introduce new products are dependent on the success of our research and development initiatives. Our inability to successfully develop and commercialise new products in a timely manner could adversely impact our business, growth, and financial condition.
- The presence of counterfeit and look-alike products, particularly in the domestic market, may harm our brand reputation, erode customer trust, and adversely impact our business and financial performance.
- Majority of our revenue from operations are generated from key states of India, including Maharashtra, Karnataka, Tamil Nadu and Gujarat which exposes our operations to potential geographical concentration risks arising from local and regional factors which may adversely affect our operations and in turn our business, results of operations and cash flows.
- Exposure to cross-border operational, regulatory, and macroeconomic risks across multiple jurisdictions may materially and adversely affect our business, cash flows, results of operations, and future prospects.
- Suboptimal capacity utilisation at our manufacturing facilities may limit operational efficiency and adversely affect our business and financial condition.
Objectives Hexagon Nutrition IPO
1. Book Running Lead Managers’ fees and commission (including underwriting commission), brokerage and selling commission, as applicable
2. Brokerage, commission/processing fee for SCSBs, Sponsor Bank and Bankers to the Offer. Brokerage, and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs
3. Fees payable to the Registrar to the Offer
4. Listing fees, SEBI filing fees, upload fees, BSE & NSE processing fees, book building software fees and other regulatory expenses
5. Printing and distribution of issue stationery
6. Advertising and marketing expenses
7. Fees payable to legal counsels
8. Fees payable to statutory auditors for the Offer
9. Fees payable to other advisors to the Offer
10. Miscellaneous
Company Contact Details
Hexagon Nutrition Ltd.
404 Global Chamber
Adarsh Nagar Link Road
Andheri (W)
Mumbai, Maharashtra, 400053
Phone: +91 22 6213 6710
Email: cs.hnpl@hexagonnutrition.com
Website: https://hexagonnutrition.com/
Registrar Contact Details
Hexagon Nutrition FAQs
The Hexagon Nutrition IPO is a MAINBOARD public issue comprising 30859704 equity shares with a face value of ₹1 each, aggregating to a total issue size of ₹138.87 Cr. The issue price has been fixed at ₹45 per equity share, and the minimum application size is 333 shares.
The IPO opens for subscription on 05 Jun 2026, and closes on 09 Jun 2026.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at ₹2.75 (6.11%).
Quick Links
Comments
